| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 880.49 | 670.55 | 520.29 | 400.94 | 228.67 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 880.49 | 670.55 | 520.29 | 400.94 | 228.67 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 16.18 | 15.61 | 2.81 | 1.65 | 0.52 |
Total Income | 896.66 | 686.16 | 523.1 | 402.59 | 229.19 |
Total Expenditure | 660.3 | 490.61 | 386.53 | 290.13 | 161.66 |
PBIDT | 236.36 | 195.55 | 136.57 | 112.46 | 67.53 |
Interest | 7.51 | 9.42 | 21.39 | 21.49 | 18.84 |
PBDT | 228.85 | 186.13 | 115.19 | 90.97 | 48.68 |
Depreciation | 57.11 | 29.3 | 27.51 | 27.87 | 20.56 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 49.14 | 40.77 | 25.93 | 19.81 | 3.37 |
Deferred Tax | -7.95 | 1.59 | -4.02 | -0.87 | 5.16 |
Reported Profit After Tax | 130.55 | 114.48 | 65.77 | 44.16 | 19.59 |
Minority Interest After NP | 0.01 | 0 | 0 | 0 | 1.43 |
Net Profit after Minority Interest | 130.55 | 114.48 | 65.77 | 44.16 | 18.16 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 130.55 | 114.48 | 65.77 | 44.16 | 18.16 |
EPS (Unit Curr.) | 14.72 | 14.46 | 10.09 | 6.78 | 11.09 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 96.35 | 85.85 | 65.52 | 65.52 | 16.38 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 26.84 | 29.16 | 26.24 | 28.04 | 29.53 |
PBDTM(%) | 25.99 | 27.75 | 22.13 | 22.68 | 21.28 |
PATM(%) | 14.82 | 17.07 | 12.64 | 11.01 | 8.56 |
The hospital chain’s EBITDA for the March 2025 quarter jumped 22.7 YoY% to ₹57.2 crore against ₹46.6 crore in Q4 FY24
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
